Rapport Therapeutics Inc.
XNAS: RAPP
Rapport Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucid...
Read More
30.97
0.35
(1.14%)
20,865
XNAS Volume
XNAS 24 Dec, 2025 10:31 AM (EST)
Not Eligible
Expensive Valuation
Technically Bullish
Rapport Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..